ALEXION PHARMACEUTICALS, INC. SEC Filings

Filed On	Filing
16 Nov 2022	SC TO-T/A
18 Oct 2022	SC TO-T
03 Oct 2022	SC TO-C
09 Aug 2021	SC 13G/A
02 Aug 2021	15-12G
23 Jul 2021	EFFECT
23 Jul 2021	EFFECT
23 Jul 2021	EFFECT
23 Jul 2021	EFFECT
23 Jul 2021	EFFECT
23 Jul 2021	EFFECT
23 Jul 2021	EFFECT
23 Jul 2021	EFFECT
23 Jul 2021	EFFECT
23 Jul 2021	Form 4: Coughlin Christopher J, Director Returned 42,347 shares to the issuer · Disposed of 7,343 Option to Purchase Common Stock (Disposition to Issuer) ($1.14M)
23 Jul 2021	Form 4: Sarin Aradhana, EVP, CFO Returned 120,253 shares to the issuer
23 Jul 2021	Form 4: Friedman Paul A, Director Returned 12,840 shares to the issuer
23 Jul 2021	Form 4: Reinsdorf Judith A, Director Returned 14,150 shares to the issuer
23 Jul 2021	Form 4: Dunsire Deborah, Director Returned 14,629 shares to the issuer
23 Jul 2021	Form 4: Carino Tanisha, EVP & CCAO Returned 59,226 shares to the issuer

Comments